Tumor glycolytic profiling through (18)F-FDG PET/CT predicts immune checkpoint inhibitor efficacy in advanced NSCLC

por Silva, Saulo Brito, Wanderley, Carlos Wagner S., Gomes Marin, José Flavio, de Macedo, Mariana Petaccia, do Nascimento, Ellen Caroline Toledo, Antonacio, Fernanda Frozoni, Figueiredo, Caroline Sales, Trinconi Cunha, Mateus, Cunha, Fernando Q., de Castro Junior, Gilberto
Publicado 2022